RxDoctor Payments Data

Jennifer Yu

Anesthesiology · Boston, MANPI 1467807164

Payments from drug & device makers

$5,439in general payments, 2019–2025

Across 91 payments — averaging $59.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$2K
  • Nevro Corp.$764
  • MML US, Inc.$480
  • SPR Therapeutics, Inc$250
  • Abbott$178
  • plus $371 from 5 others

What the payments were for

  • Speaking & faculty fees$1,32024%
  • Travel & lodging$591%
  • Food & beverage$4,06075%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)14$1,827
Boston Scientific27$1,569
Nevro Corp.12$764
MML US, Inc.29$480
SPR Therapeutics, Inc2$250
Abbott2$178
Painteq LLC1$122
AstraZeneca1$104
Globus Medical1$65
Si-bone, Inc.1$52
Stryker1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,439 in reported general payments places this provider in the 90th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$65,763
Medicare patients
243
Services billed
602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin113$1,115
Duloxetine Hcl36$801
Tizanidine Hcl37$426
Pregabalin14$130

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →